Telecom Italia reduces Huawei’s 5G share but not completely! Apple has removed thousands of gaming apps in China due to regulatory concerns. Bytedance drug development?

On Wednesday, Telecom Italia (TIM) decided to keep Nokia as a supplier and reduce Huawei’s share of planned 5G network equipment purchases, as security concerns demanded that the Chinese company be excluded. According to the Wall Street journal reported that apple recently warned China application developers, as the government regulation of rectification, thousands of electronic game from app store shelves. Live rely on advertising and sales of bytes have been beating is trying to diversify. The company’s recruitment page displays, the proud of content algorithm, company has begun looking for drug research and development of artificial intelligence in Shanghai and Beijing talents.

Italy has not banned Huawei entirely

The US has lobbied Italy and other European Allies to avoid using Huawei equipment, saying it could pose a security risk, a charge huawei denies. So far, Italy has refused to ban Huawei outright.

Earlier this year, Telecom Italia was considering splitting the supply contract for the 5G wireless Access Network (RAN) portion between Huawei and Ericsson of Sweden. RAN’s infrastructure includes base stations and antennas that connect smartphones to mobile networks, which account for most of the cost of the new network.

Finland’s Nokia, previously one of TIM’s suppliers of mobile radio access network equipment, missed out on a 5G RAN order, according to the source. But the agreement was later reconsidered.

“Ericsson will provide most of the equipment, while Huawei and Nokia will each get 20-25 percent,” one of the sources said on Wednesday. Another source said: “The negotiations are still going on on issues such as how much to cut.”

In July, Telecom Italia did not invite Huawei to tender for a contract to supply 5G equipment for its core network, where sensitive data is processed.

Apple has taken down a number of apps in China amid tight regulations

Developers of paid games and apps with paid features built into them must provide government approval by the end of the year or the app will be taken down, Apple said. “As far as we know, only a small percentage of games are actually licensed,” says Rich Bishop, chief executive of ChinaInApp. The CEO of ChinaInApp has partnered with Western companies to bring their apps to China.

At least 94,000 games have been removed from App stores in China this year, compared with 25,000 in 2019, according to Sensor Tower, an application research company.

Apple said its app store was subject to local regulations, which could include requests for removal. Earlier this month, the Cyberspace Administration of China banned 105 apps from its app store, alleging that their content violated at least one of three cyber security laws.

Bytedance is moving into medicine

“We are looking for candidates to join our team for cutting-edge research in drug discovery and manufacturing driven by artificial intelligence algorithms,” according to a job Posting on Bytedance’s website.

The drug discovery team is seeking to fill at least five positions, including internships, under the ByteDance AI Lab. The AI-focused RESEARCH and development unit was set up in 2016 to serve content, but the lab could expand its reach into pharmaceuticals.

“Given the number of areas of AI research, applications of these new technologies can be found in every segment of our product portfolio,” according to a description on the ByteDance AI Lab website.

All five drug discovery positions require a PhD in computer science, mathematics, computational biology, or computational chemistry. According to the job Posting, the candidate will be engaged in drug development work, such as design, identification and simulation.

The pharmaceutical industry has become a new target for technology companies. Tencent’s own AI medicine team, also affiliated with the company’s AI lab, has been actively publishing research results since at least August 2019. Baidu plans to raise $2 billion for a biotechnology start-up focused on drug discovery and artificial intelligence diagnostics, Reuters reported in September. Huawei has also made efforts in drug development and medical imaging through its cloud computing division.

Leave a Reply

Your email address will not be published. Required fields are marked *